Adverse outcomes and mortality in users of non-steroidal anti-inflammatory drugs who tested positive for SARS-CoV-2: A Danish nationwide cohort study

By Lund LC, Kristensen KB, Reilev M, et al
Published September 8, 2020

Key Takeaways

Researchers conducted a population-based cohort study using Danish administrative and health registries to examine if the risk of adverse outcomes and mortality is higher in correlation with using NSAIDs during SARS-CoV-2 infection. All Danish residents who tested positive for the infectious agent of COVID-19 were identified and grouped in two: users and non-users of NSAIDs. Outcomes suggest no correlation of using NSAIDs with 30-day mortality, hospitalization, ICU admission, mechanical ventilation, or renal replacement therapy in Danish individuals who tested positive for SARS-CoV-2.

Read the full article on PLoS Medicine.

Share with emailShare to FacebookShare to LinkedInShare to Twitter